$CLVT
CLARIVATE PLC Stock $clvt

$clvt Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000176404620000031 Filed on May 04, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$240.6M	$234.0M
YoY Change	2.81%
Cost Of Revenue	$82.70M	$89.30M
YoY Change	-7.39%
Gross Profit	$157.9M	$144.8M
YoY Change	9.05%
Gross Profit Margin	65.63%	61.87%
Selling, General & Admin	$133.1M	$92.30M
YoY Change	44.16%
% of Gross Profit	84.27%	63.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.329M	$2.051M
YoY Change	13.55%
% of Gross Profit	1.47%	1.42%
Operating Expenses	$268.9M	$259.9M
YoY Change	3.45%
Operating Profit	-$28.31M	-$25.92M
YoY Change	9.21%
Interest Expense	$30.94M	$33.10M
YoY Change	-6.53%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$114.9M	-$59.02M
YoY Change	94.65%
Income Tax	$14.75M	$240.0K
% Of Pretax Income
Net Earnings	-$129.6M	-$59.26M
YoY Change	118.75%
Net Earnings / Revenue	-53.88%	-25.32%
Basic Earnings Per Share	-$0.38	-$0.27
Diluted Earnings Per Share	-$0.38	-$0.27
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$308.0M	$3.000M
YoY Change	10166.67%
Cash & Equivalents	$308.0M	$28.05M
Short-Term Investments
Other Short-Term Assets	$22.10M	$0.00
YoY Change
Inventory
Prepaid Expenses	$52.10M
Receivables	$343.2M	$343.1M
Other Receivables	$0.00
Total Short-Term Assets	$728.2M	$3.000M
YoY Change	24174.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.95M
YoY Change
Goodwill	$1.823B
YoY Change
Intangibles	$2.282B
YoY Change
Long-Term Investments		$698.0M
YoY Change
Other Assets	$22.82M
YoY Change
Total Long-Term Assets	$4.271B	$699.0M
YoY Change	510.99%
TOTAL ASSETS
Total Short-Term Assets	$728.2M	$3.000M
Total Long-Term Assets	$4.271B	$699.0M
Total Assets	$4.999B	$702.0M
YoY Change	612.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.58M	$6.000M
YoY Change	376.38%
Accrued Expenses	$265.0M
YoY Change
Deferred Revenue	$472.1M	$461.9M
YoY Change	2.2%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.60M
YoY Change
Total Short-Term Liabilities	$778.3M	$7.000M
YoY Change	11018.86%
LONG-TERM LIABILITIES
Long-Term Debt	$1.915B	$0.00
YoY Change
Other Long-Term Liabilities	$18.55M	$24.00M
YoY Change	-22.7%
Total Long-Term Liabilities	$1.934B	$24.00M
YoY Change	7958.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$778.3M	$7.000M
Total Long-Term Liabilities	$1.934B	$24.00M
Total Liabilities	$2.906B	$31.00M
YoY Change	9274.08%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$3.033B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.926B	$990.8M
YoY Change
Total Liabilities & Shareholders Equity	$4.999B	$702.0M
YoY Change	612.12%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$129.6M	-$59.26M
YoY Change	118.75%
Depreciation, Depletion And Amortization	$2.329M	$2.051M
YoY Change	13.55%
Cash From Operating Activities	$46.11M	$42.45M
YoY Change	8.6%
INVESTING ACTIVITIES
Capital Expenditures	$19.40M	-$6.000M
YoY Change	-423.25%
Acquisitions	$885.3M	$0.00
YoY Change
Other Investing Activities	-$881.6M	$0.00
YoY Change
Cash From Investing Activities	-$901.0M	-$5.957M
YoY Change	15024.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$540.6M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.092B	-$33.84M
YoY Change	-3326.17%
NET CHANGE
Cash From Operating Activities	$46.11M	$42.45M
Cash From Investing Activities	-$901.0M	-$5.957M
Cash From Financing Activities	$1.092B	-$33.84M
Net Change In Cash	$234.7M	$2.470M
YoY Change	9403.32%
FREE CASH FLOW
Cash From Operating Activities	$46.11M	$42.45M
Capital Expenditures	$19.40M	-$6.000M
Free Cash Flow	$26.71M	$48.45M
YoY Change	-44.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001764046
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	306874115	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	306874115	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	364938052	shares
CY2019Q4	ccc	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	18042000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2282348000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1828640000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	1823084000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1328045000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22818000	USD
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-38911
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CLARIVATE ANALYTICS PLC
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Friars House
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	160 Blackfriars Road
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SE1 8EZ
CY2020Q1	dei	Entity Address Country EntityAddressCountry	GB
CY2020Q1	dei	Country Region CountryRegion	44
CY2020Q1	dei	City Area Code CityAreaCode	207
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	4334000
CY2020Q1	dei	Security12b Title Security12bTitle	Ordinary shares
CY2020Q1	dei	Trading Symbol TradingSymbol	CCC
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12600000	USD
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9000000	USD
CY2020Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	ccc	Liabilities Held For Sale LiabilitiesHeldForSale	0	USD
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	365097108	shares
CY2019Q4	ccc	Liabilities Held For Sale LiabilitiesHeldForSale	26868000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308021000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	778320000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	650998000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2019Q1	ccc	Transition Integration And Other Expenses TransitionIntegrationAndOtherExpenses	1161000	USD
CY2020Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2850000	USD
CY2020Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1915452000	USD
CY2019Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1628611000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	18774000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19723000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	9000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	343177000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333858000	USD
CY2020Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	52101000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18553000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18891000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	40710000	USD
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22099000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11750000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	94638000	USD
CY2020Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	48547000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80229000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	30619000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	728248000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	493076000	USD
CY2020Q1	ccc	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	22953000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22130000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18632000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15646000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19488000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103995000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85448000	USD
CY2020Q1	us-gaap	Assets Assets	4999092000	USD
CY2019Q4	us-gaap	Assets Assets	3791371000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	28583000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	26458000	USD
CY2020Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	239661000	USD
CY2019Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	159217000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	472101000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407325000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25375000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64189000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	2905966000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	7754000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6032000	USD
CY2019Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-5617000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	268900000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	259944000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28308000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25919000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	30940000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	33101000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59248000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	2051000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49112000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56106000	USD
CY2020Q1	ccc	Transaction Expenses TransactionExpenses	26689000	USD
CY2019Q1	ccc	Transaction Expenses TransactionExpenses	10270000	USD
CY2020Q1	ccc	Transition Integration And Other Expenses TransitionIntegrationAndOtherExpenses	2232000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	2430959000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	3033033000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2208529000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-13349000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-4879000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-926558000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-843238000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2093126000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1360412000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4999092000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3791371000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	234025000	USD
CY2020Q1	ccc	Cost Of Revenues Excluding Depreciation And Amortization CostOfRevenuesExcludingDepreciationAndAmortization	82399000	USD
CY2019Q1	ccc	Cost Of Revenues Excluding Depreciation And Amortization CostOfRevenuesExcludingDepreciationAndAmortization	89267000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	86948000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	92296000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17469000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3176000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2329000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59020000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	240000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-74001000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-59260000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	343129833	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	217526426	shares
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-74001000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-59260000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2890000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-1946000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	67000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-19000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5513000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1824000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3751000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-82471000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63011000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1050607000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3176000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-59260000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3751000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	990772000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1360412000	USD
CY2020Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-9319000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	808120000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16384000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-74001000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2093126000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-74001000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-59260000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51441000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58157000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	689000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4214000	USD
CY2019Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3946000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16502000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3176000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1008000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-2099000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7015000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5440000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29279000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13362000	USD
CY2019Q1	ccc	Proceedsfrom Issuanceof Ordinary Shares Net ProceedsfromIssuanceofOrdinarySharesNet	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1091606000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7349000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	9813000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-54644000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1507000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	758000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4942000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-12035000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-9049000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40726000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	68929000	USD
CY2020Q1	ccc	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5919000	USD
CY2019Q1	ccc	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5696000	USD
CY2020Q1	ccc	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	5876000	USD
CY2019Q1	ccc	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	5750000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-52109000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3988000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46106000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42453000	USD
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	19395000	USD
CY2019Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5957000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	885323000	USD
CY2019Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	3751000	USD
CY2019Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-900967000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5957000	USD
CY2020Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3150000	USD
CY2019Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3836000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	65000000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	30000000	USD
CY2020Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4115000	USD
CY2019Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5014000	USD
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020Q1	ccc	Proceeds From Debt Restructure ProceedsFromDebtRestructure	360000000	USD
CY2019Q1	ccc	Proceeds From Debt Restructure ProceedsFromDebtRestructure	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540597000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10420000	USD
CY2020Q1	ccc	Proceedsfrom Issuanceof Ordinary Shares Net ProceedsfromIssuanceofOrdinarySharesNet	278708000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308021000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25575000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76139000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25584000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33836000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2013000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-190000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	234732000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2470000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28045000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28054000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	2850000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28054000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	11405000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	21023000	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	4797000	USD
CY2019Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	7789000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9528000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6836000	USD
CY2020Q1	us-gaap	Nature Of Operations NatureOfOperations	Background and Nature of Operations<div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Clarivate Analytics Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), a public limited company organized under the laws of Jersey, Channel Islands, was incorporated as a Jersey limited company on January 7, 2019. Pursuant to the definitive agreement entered into to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation, ("Churchill") (the “2019 Transaction”), the Company was formed for the purposes of completing the 2019 Transaction and related transitions and carrying on the business of Jersey, and its subsidiaries.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enables users across government and academic institutions, life science companies and research and development (“R&D”) intensive corporations to discover, protect and commercialize their innovations. Our Science Product Group consists of our Web of Science and Life Science Product Lines. Both Product Lines provide curated, high-value, structured information that is delivered and embedded into the workflows of our customers, which include research intensive corporations, life science organizations and universities world-wide. Our Intellectual Property ("IP") Product Group consists of our Derwent, CompuMark and MarkMonitor Product Lines. These Product Lines help manage customer’s end-to-end portfolios of intellectual property from patents to trademarks to corporate website domains.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2019, we entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated February 26, 2019, and Amendment No. 2 to the Agreement and Plan of Merger, dated March 29, 2019, collectively, the “Merger Agreement”) by and among Churchill, Jersey, CCC Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Clarivate (“Delaware Merger Sub”), Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands and wholly owned subsidiary of Clarivate (“Jersey Merger Sub”), and the Company, which, among other things, provided for (i) Jersey Merger Sub to be merged with and into Jersey with Jersey being the surviving company in the merger (the “Jersey Merger”) and (ii) Delaware Merger Sub to be merged with and into Churchill with Churchill being the surviving corporation in the merger (the “Delaware Merger”), and together with the Jersey Merger, the “Mergers”.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 13, 2019, the 2019 Transaction was consummated, and Clarivate became the sole managing member of Jersey, operating and controlling all of the business and affairs of Jersey, through Jersey and its subsidiaries. Following the consummation of the 2019 Transaction on May 13, 2019, the Company’s ordinary shares and warrants began trading on the New York Stock Exchange. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The 2019 Transaction was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Under this method of accounting Churchill was treated as the "acquired" company for financial reporting purposes. This determination was primarily based on post 2019 Transaction relative voting rights, composition of the governing board, size of the two entities pre-merger, and intent of the 2019 Transaction. Accordingly, for accounting purposes, the 2019 Transaction was treated as the equivalent of the Company issuing stock for the net assets of Churchill. The net assets of Churchill, were stated at historical cost, with no goodwill or other intangible assets resulting from the 2019 Transaction. Reported amounts from operations included herein prior to the 2019 Transaction are those of Jersey.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2020, the Company consummated a public offering of </span><span style="font-family:inherit;font-size:10pt;"><span>27,600,000</span></span><span style="font-family:inherit;font-size:10pt;"> ordinary shares at $</span><span style="font-family:inherit;font-size:10pt;"><span>20.25</span></span><span style="font-family:inherit;font-size:10pt;"> per share. After this offering, Onex Corporation and Baring Private Equity Asia Limited ("BPEA") continue to beneficially own approximately </span><span style="font-family:inherit;font-size:10pt;"><span>38.3%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s ordinary shares, down from approximately </span><span style="font-family:inherit;font-size:10pt;"><span>70.8%</span></span><span style="font-family:inherit;font-size:10pt;"> of the ordinary shares beneficially owned by Onex and BPEA immediately after the closing of our merger with Churchill Capital Corp in 2019.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Risks and Uncertainties</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the World Health Organization characterized COVID-19 as a pandemic. The rapid spread of COVID-19 and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">However, we continue to assess the potential effect on our financial position, results of operations, and cash flows. If the global pandemic continues to evolve into a prolonged crisis, the effects could have an adverse impact on the Company's results of operations, financial condition and cash flows.</span></div>
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	27600000	shares
CY2020Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.25
CY2019Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.74
CY2019Q3	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.60
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	265341	USD
CY2019Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	267800	USD
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-64438	USD
CY2019Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-100501	USD
CY2020Q1	ccc	Business Combinations Pro Forma Expense Reduction Increase Decrease BusinessCombinationsProFormaExpenseReductionIncreaseDecrease	-24926000	USD
CY2019Q1	ccc	Business Combinations Pro Forma Expense Reduction Increase Decrease BusinessCombinationsProFormaExpenseReductionIncreaseDecrease	25365000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15072000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11043000	USD
CY2020Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	358249000	USD
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	350369000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15072000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16511000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	343177000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333858000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16511000	USD
CY2020Q1	ccc	Accounts Receivable Allowance For Credit Loss Additional Provisions AccountsReceivableAllowanceForCreditLossAdditionalProvisions	0	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11043000	USD
CY2020Q1	ccc	Accounts Receivable Allowancefor Credit Loss Accounting Change AccountsReceivableAllowanceforCreditLossAccountingChange	10097000	USD
CY2020Q1	ccc	Accounts Receivable Allowance For Credit Loss Increase Decrease From Exchange Differences AccountsReceivableAllowanceForCreditLossIncreaseDecreaseFromExchangeDifferences	-493000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2321000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	705683000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2118073000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2323087000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	658875000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1664212000	USD
CY2020Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2988031000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	705683000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48509000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	41528000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25556000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23486000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22953000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18042000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2329000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	2051000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2823756000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2282348000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2487515000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	658875000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1828640000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49112000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56106000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1328045000	USD
CY2020Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	499067000	USD
CY2020Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	4028000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	1823084000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	221000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	79000	USD
CY2020Q2	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	533000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	78000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	40000	USD
CY2020Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1737000	USD
CY2019Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.02183
CY2020Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.01695
CY2020Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	979000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	226000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	40000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	19000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	18000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	246000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	241000	USD
CY2020Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1956850000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1665000000	USD
CY2020Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26670000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	25205000	USD
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2128000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2184000	USD
CY2020Q1	us-gaap	Debt Current DebtCurrent	12600000	USD
CY2019Q4	us-gaap	Debt Current DebtCurrent	9000000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1915452000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1628611000	USD
CY2020Q1	ccc	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	242474000	USD
CY2019Q1	ccc	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	234189000	USD
CY2020Q1	ccc	Contractwith Customer Liability Adjustments ContractwithCustomerLiabilityAdjustments	1882000	USD
CY2019Q1	ccc	Contractwith Customer Liability Adjustments ContractwithCustomerLiabilityAdjustments	164000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	234025000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333858000	USD
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364938052	shares
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407325000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19723000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	343177000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	472101000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	18774000	USD
CY2020Q1	ccc	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	-9319000	USD
CY2020Q1	ccc	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	-64776000	USD
CY2020Q1	ccc	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	949000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	331295000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	391102000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	17112000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	343113000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	461928000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	17987000	USD
CY2019Q1	ccc	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	-11818000	USD
CY2019Q1	ccc	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	-70826000	USD
CY2019Q1	ccc	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	-875000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	105150000	USD
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	62328000	USD
CY2020Q1	ccc	Revenue Remaining Performance Obligation Expected Timing Percentage RevenueRemainingPerformanceObligationExpectedTimingPercentage	0.65
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.35
CY2020Q1	ccc	Revenue Remaining Performance Obligation Percentage Expectedto Be Recognizedin12months RevenueRemainingPerformanceObligationPercentageExpectedtoBeRecognizedin12months	0.21
CY2020Q1	ccc	Revenue Remaining Performance Obligation Percentage Expectedto Be Recognizedin3to10 Years RevenueRemainingPerformanceObligationPercentageExpectedtoBeRecognizedin3to10Years	0.14
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00
CY2020Q1	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	2895638	shares
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17469000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3176000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-2000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	78000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4909000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2863000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74001000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-59260000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	343129833	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59248000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	240000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59020000	USD
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38149453	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24323190	shares
CY2019	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	132.13667
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	217526426	shares
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2020Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	USD
CY2019Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	231000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	9506000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	7754000	USD
CY2020Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	6647000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	10613000	USD
CY2020Q1	us-gaap	Severance Costs1 SeveranceCosts1	6574000	USD
CY2020Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	508000	USD
CY2020Q1	ccc	Restructuring Legal Fees RestructuringLegalFees	666000	USD

Files In Submission

Name	View Source	Status
0001764046-20-000031-index-headers.html	Edgar Link	pending
0001764046-20-000031-index.html	Edgar Link	pending
0001764046-20-000031.txt	Edgar Link	pending
0001764046-20-000031-xbrl.zip	Edgar Link	pending
ccc-20200331.xsd	Edgar Link	pending
ccc-20200331_cal.xml	Edgar Link	unprocessable
ccc-20200331_def.xml	Edgar Link	unprocessable
ccc-20200331_lab.xml	Edgar Link	unprocessable
ccc-20200331_pre.xml	Edgar Link	unprocessable
ex101-amendmentno1tosh.htm	Edgar Link	pending
exhibit31-q12020.htm	Edgar Link	pending
exhibit32-q12020.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ns202003clarivateanaly.htm	Edgar Link	pending
ns202003clarivateanaly_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLVT
CLARIVATE PLC Stock $clvt

2020 Q1 Form 10-Q Financial Statement

#000176404620000031 Filed on May 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT CLARIVATE PLC Stock $clvt

2020 Q1 Form 10-Q Financial Statement

#000176404620000031 Filed on May 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT
CLARIVATE PLC Stock $clvt